spacer
  Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
spacer
spacer CDC Centers for Disease Control and Prevention Home Page spacer
CDC en Español
spacer
 
spacer
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
spacer
spacer
spacer
spacer
  MPEP Content
space
arrow MPEP Home
space
arrow Laboratory Quality Assurance
space
arrow Program Description
space
arrow Enrollment Forms
space
arrow Shipment Schedule
space
arrow MPEP Privacy Policy
space
arrow Publications
space
arrow Presentations
space
arrow Contact Us
space

  Current Programs
space
arrow HIV-1 Rapid
space
arrow Tb Drug Susceptibility
space

  Previous Programs
space
arrow HIV Viral Load
space
arrow HIV-1 Antibody
space
arrow HTLV I/II Antibody
space
arrow HIV-1 p24 Antigen
space
arrow HIV-1 RNA
space
arrow TLI (CD4 Testing)
space
arrow Tb Nucleic Acid Amp.
space

  Related Content
space
arrow CLIA
space
arrow Genetics
space
arrow International
space
arrow TB
space
arrow HIV
space
arrow IQLM
space
arrow MASTER
space
arrow Monitoring
space
arrow Publications
space
arrow Training
space
spacer spacer
spacer
spacer
spacer
Retroviral/AIDS Related Publications 1988 to Present -
updated March 30, 2005
spacer
spacer
  1. Cross, G. D., Mandy, Francis, Nicholson, J. K. A., and McDougal, J. S. Guidelines for Performing Single Platform Absolute CD4+ T-Cell Determinations with CD45 Gating in Persons Infected with Human Immunodeficiency Virus (HIV). MMWR.Morbidity and Mortality Weekly Report Vol. 52 RR-2, 1-13. 1-31-2003.
    Ref Type: Report
    Ref ID: 307

  2. Ridderhof JC, Williams LO, Legios S, et al: Assessment of laboratory performance of nucelic acid amplification tests for decetion of mycobacterium tuberculosis. J.Clin.Microbiol. 2003;41:5258-5261.
    Ref ID: 330

  3. Schalla, W. O., Stankovic, Ana, Martin, R., and et al. Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus. MMWR.Morbidity and Mortality Weekly Report Vol. 52 No. RR-3, 1-15. 2003.
    Ref Type: Report
    Ref ID: 319

  4. Cross GD, Handsfield JH: Comparison of Absolute CD4 and CD8 T-cell Counts, Multi-platform vs. Single-Platform Methods: Results from a Performance Evaluation Program. International Aids Conference 2 A.D.;(In Press)
    Ref ID: 300

  5. Hofherr LK, Francis DP, Astles JR, Schalla WO: HIV-1 Antiretroviral Resistance Testing Laboratories. Clin Lab Sci 2002;15:213-219.
    Ref ID: 314

  6. Schalla WO, et al: CDC Guidelines for Reporting HIV Laboratory Test Results. Lab Med 2002;33:2-6.
    Ref ID: 311

  7. Schalla, W. O. and et al. Notice to Readers: Approval of a New Rapid Test for HIV Antibody. MMWR.Morbidity and Mortality Weekly Report vol. 51 RR 46, 1-3. 11-22-2002.
    Ref Type: Report
    Ref ID: 309

  8. Schalla, W. O. and et al. Notice to Readers: Potential Shortage of Supplemental Test Kits for Detecting HIV-1 Antibodies. MMWR.Morbidity and Mortality Weekly Report Vol. 51 RR-18, 395-396. 5-10-2002.
    Ref Type: Report
    Ref ID: 312

  9. Francis DP, Peddecord KM, Hofherr LK, Astles JR, Schalla WO: Viral Load Test Reports. Arch Pathol Lab Med 2001;125:1546-1554.
    Ref ID: 289

  10. Schalla, W. O., Schulte, Joann, and et al. Guidelines for Laboratory Test Result Reporting of Human Immunodeficiency Virus Type 1 Ribonucleic Acid Determination. MMWR.Morbidity and Mortality Weekly Report Vol. 50 RR-20, 1-12. 11-16-2001.
    Ref Type: Report
    Ref ID: 310

  11. Cross GD, Handsfield JH, Schalla WO: Extreme Values Reported for Cd4 Absolute Cell Counts by Laboratories Using Dual-Platform Methods: Results From a Performance Evaluation Program. Cytometry 2000;42:314
    Ref ID: 322

  12. Williams LO, Blumer SO, Schalla WO, et al: Laboratory Performance in Human T-Lymphotrophic Virus Types I/II (HTLV) Analysis. Transfusion 2000;40:1514-1521.
    Ref ID: 298

  13. Cross GD, Handsfield JH, Schalla WO: CD4 T-Cell Enumeration: Single-Platform Methods May Yield More Reproducible Results Than Multi-Platform Methods. Cytometry 1999;38:327
    Ref ID: 321

  14. Francis DP, Peddecord KM, Hofherr LK, Benenson AS, Schalla WO: T-Lymphocyte Immunophenotyping Blind Proficiency Testing: A Model System for CD4+ T-Cells. Clin Lab Sci 1999;12:278-289.
    Ref ID: 11

  15. Astles JR, Lipman HB, Schalla WO, et al: Impact of Quality Control on Accuracy in Enzyme Immunoassay Testing from Human Immunodeficiency Virus Type 1 Antibodies. Arch.Pathol.Lab.Med. 1998;122:700-707.
    Ref ID: 14

  16. Cross GD, Handsfield JH, Schalla WO: Comparison of Absolute CD4 T-cell Counts, Multi-platform vs. Single-Platform Methods: Results for a Performance Evaluation Program. Cytometry 1998;34:296
    Ref ID: 183

  17. Rosner E, Siragusa M, Schalla WO, Cross GD, Cohn RD, Hearn TL: Assessment of the Impact of a CD4+ T-Cell Testing Laboratory Improvement Program. Arch.Pathol.Lab.Med. 1998;122:512-519.
    Ref ID: 5

  18. Cruz JR, Schalla WO, Larsen SA: Quality Assessment Activities in Latin America and the Caribbean. MLO 1997;29:40-42.
    Ref ID: 55

  19. Nicholson, J. K. A., Hearn, T. L., Cross, G. D., and White, M. D. 1997 Revised Guidelines for Performing CD4+ T-Cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV). MMWR.Morbidity and Mortality Weekly Report 46(RR-2), 1-29. 1-10-1997.
    Ref Type: Report
    Ref ID: 73

  20. Schalla, W. O. Performance Evaluation Programs for Determining HIV-1 Viral Loads, Testing for HIV p24 Antigen, and Identifying Mycobacterium tuberculosis Using Nucleic Acid Amplification Tests. MMWR.Morbidity and Mortality Weekly Report 46(07), 155-156. 2-21-1997.
    Ref Type: Report
    Ref ID: 54

  21. Cross GD, Schalla WO, Taylor CL, Siragusa M, Cohn RD, Gaunt EE: Precision of Absolute CD4 Counts Between Laboratories: Results of a Pilot Study. Cytometry 1996;26:86
    Ref ID: 182

  22. Hearn TL: Standards of Laboratory Practice for Human Immunodeficiency Virus (HIV) Testing, in Schochetman G, George JR (eds): Springer-Verlag; 1994:
    Ref ID: 84

  23. Performance Evaluation Program for Mycobacterium tuberculosis Drug-Susceptibility Testing Process. MMWR.Morbidity and Mortality Weekly Report 43(1), 17-18. 1-14-1994.
    Ref Type: Report
    Ref ID: 100

  24. Hancock JS, Taylor RN, Johnson CA, Gerber AR, Schalla WO: Quality of Laboratory Performance in Testing for Human Immunodeficiency Virus Type 1 Antibody. Identification of Variables Associated with Laboratory Performance. Arch.Pathol.Lab.Med. 1993;117:1148-1155.
    Ref ID: 86

  25. Peddecord KM, Benenson AS, Hofherr LK, et al: Variability of Reporting and Lack of Adherence to Consensus Guidelines in Human T-lymphocyte Immunophenotyping Reports: Results of a Case Series. J.Acquir.Immune.Defic.Syndr. 1993;6:823-830.
    Ref ID: 109

  26. Peddecord KM, Hofherr LK, Benenson AS, et al: Sources of Influence in Changing Policies and Procedures for HIV-1 Testing. Clin Lab Sci 1993;6:359-365.
    Ref ID: 194

  27. D.J. Hewitt, K.M. Peddecord, D.P. Francis, A.S. Benenson, L.K. Hofherr, K.L. Ferran, R.S. Garfein, and A.R. Gerber. Content and Design of Laboratory Report Forms For Human Immunodeficiency Virus Type 1 Antibody Testing. Amer. J. Clin. Path. 1992, Aug. 98:199-204.

  28. Blumer SO, Hearn TL, Schalla WO, Cross GD, Valdiserri RO: Human T-lymphotropic Virus Type I/II. Status of Enzyme Immunoassay and Western Blot Testing in the United States in 1989 and 1990. Arch.Pathol.Lab.Med. 1992;116:471-476.

  29. Ref ID: 111

  30. Cross GD, Schalla WO, Hancock JS, et al: Analytic Sensitivity and Specificity of Enzyme Immunoassay Results in Testing for Human Immunodeficiency Virus Type 1 Antibody. Arch.Pathol.Lab.Med. 1992;116:477-481.
    Ref ID: 88

  31. Francis DP, Peddecord KM, Ferran KL, et al: Use of a Modified Nominal Group Process for Improving Laboratory Performance in Human Immunodeficiency Virus Type 1 Antibody Testing. Reaching Consensus on Three Questions Concerning HIV-1 Testing. Clinical Laboratory Management Review 1992;6:537-538-543-546.
    Ref ID: 110

  32. Hofherr LK, Peddecord KM, Benenson AS, et al: Methods for a Model Blind Proficiency Testing System. Clin Lab Sci 1992;5:160-164.
    Ref ID: 213

  33. Peddecord KM, Benenson AS, Hofherr LK, et al: Analytic Results of HIV-1 Testing Using Blind Proficiency Testing. Clin Lab Sci 1992;5:165-171.
    Ref ID: 114

  34. Peddecord KM, Benenson AS, Hofherr LK, et al: Identification of Nonanalytic Issues in HIV-1 Antibody Testing Using Blind Proficiency Testing. Clin Lab Sci 1992;5:172-176.
    Ref ID: 113

  35. Schalla, W. O. and et al. Availability of Flow Cytometric Immunophenotyping of Lymphocytes to Hospital Patients -- United States, 1990. MMWR.Morbidity and Mortality Weekly Report 41(33), 608-610. 8-21-1992. Atlanta, GA, Centers for Disease Control.
    Ref Type: Report
    Ref ID: 196

  36. Schalla, W. O., Blumer, S. O., and Hearn, T. L. Update: Serologic Testing for Human T-Lymphotropic Virus Type I -- United States, 1989 and 1990. MMWR.Morbidity and Mortality Weekly Report 41(15), 259-262. 4-17-1992.
    Ref Type: Report
    Ref ID: 97

  37. Taylor RN: From the CDC: The Laboratory Performance Information and Exchange System. MLO 1992;
    Ref ID: 202

  38. A.R. Gerber, G.D. Cross, W.O. Schalla, J.S. Hancock, H.W. Muir, T.L. Hearn, and R.O. Valdiserri. Evaluation of Laboratory Performance of T-Lymphocyte Immunophenotyping In Support of Early HIV-1 Intervention and Prevention. Publication of Abstracts, VII International Conference on AIDS, Florence, Italy, June 16-21, 1991.

  39. Blumer, S. O., Schalla, W. O., and Cross, G. D. Interpretive Criteria Used to Report Western Blot Results for HIV-1-Antibody Testing -- United States. MMWR.Morbidity and Mortality Weekly Report 40(40), 692-695. 10-11-1991.
    Ref Type: Report
    Ref ID: 87

  40. G.D. Cross, W.O. Schalla, S.O. Blumer, T.L. Hearn, and R.O. Valdiserri. Enzyme Immunoassay (EIA) Results. American Society for Microbiology May 1991; Dallas, Texas.

  41. Gerber AR, Valdiserri RO, Johnson CA, Schwartz RE, Hancock JS, Hearn TL: Quality of Laboratory Performance in Testing for Human Immunodeficiency Virus Type 1 Antibody. Variables Associated in Multivariate Analyses. Arch.Pathol.Lab.Med. 1991;115:1091-1096.
    Ref ID: 89

  42. R.N. Taylor, G.D. Cross, S.O. Blumer, A.R. Gerber, W.O. Schalla, and T.L. Hearn. Analytic Specificities and Sensitivities of Indirect Immunofluorescence Results In Testing for Human Immunodeficiency Virus Type 1 (HIV-1) Antibody From 1988 to 1990. Publication of Abstracts, VII International Conference on AIDS, Florence, Italy, June 16-21, 1991.

  43. S.O. Blumer, W.O. Schalla, G.D. Cross, J.S. Hancock, H.W. Muir, and T.L. Hearn. Analysis of Indeterminate Human T-lymphotropic Virus Type I (HTLV-I) Western Blot Interpretations Reported for HTLV-Type II Infected Individuals. Publication of Abstracts, VII International Conference on AIDS, Florence, Italy, June 16-21, 1991.

  44. T.L. Hearn, R.O. Valdiserri, C.A. Johnson, J.S. Hancock, R.E. Schwartz, and A.R. Gerber. Correlation Between Laboratory Personnel Parameters and The Quality of HIV-1 Antibody Testing In U.S. Laboratories. Publication of Abstracts, VII International Conference on AIDS, Florence, Italy, June 16-21, 1991.

  45. Taylor RN: Information About AIDS. Ann.Intern.Med. 1991;115:160
    Ref ID: 201

  46. Valdiserri RO, Cross GD, Gerber AR, Schwartz RE, Hearn TL: Capacity of U.S. Labs to Provide TLI in Support of Early HIV-1 Intervention. Am.J.Public Health 1991;81:491-494.
    Ref ID: 90

  47. W.O. Schalla, G.D. Cross, S.O. Blumer, J.S. Hancock, A.R. Gerber, H.W. Muir, and T.L. Hearn. Update On Western Blot Testing: Performance Evaluation of Laboratories That Test For Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies. Publication of Abstracts, VII International Conference on AIDS, Florence, Italy, June 16-21, 1991.

  48. A.R. Gerber, C.A. Johnson, R.E. Schwartz, T.L. Hearn, and R.O. Valdiserri. Association of Performance On EIA for HIV-1 Antibody With Laboratory Characteristics And Testing Practices. Publication of Abstracts for the Sixth International AIDS Conference, June 20-24, 1990, San Francisco, California.

  49. Blumer, S. O. and Schalla, W. O. Indeterminate Western Blot Results on Human T-Lymphotropic Virus Type I/II (HTLV)-I/II) Antibody-Positive Samples. 1. 2-26-1990. MPEP Performance Bulletin.
    Ref Type: Report
    Ref ID: 149

  50. Blumer, S. O., Cross, G. D., and Schalla, W. O. Laboratory Reports and Reporting the Results of Human immunodeficiency Virus Type 1 (HIV-1) Testing. 2. 5-10-1990. MPEP Performance Bulletin.
    Ref Type: Report
    Ref ID: 150

  51. Gerber, A. R., Schalla, W. O., and Hearn, T. L. Update: Serologic Testing for HIV-1 Antibody --United States, 1988 and 1989. MMWR.Morbidity and Mortality Weekly Report 39(22), 380-383. 6-8-1990.
    Ref Type: Report
    Ref ID: 96

  52. MPEP Performance Bulletin No. 1. Indeterminate Western Blot Results On Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Antibody-Positive Samples. Feb. 26, 1990. CDC Model Performance Evaluation Program. (Prepared by S.O. Blumer and W.O. Schalla.)

  53. MPEP Performance Bulletin No. 2. Laboratory Reports and Reporting the Results of Human Immunodeficiency Virus Type 1 (HIV-1) Testing. May 10, 1990. CDC Model Performance Evaluation Program. (Prepared by S.O Blumer, G.D. Cross, and W.O. Schalla.)

  54. S.O. Blumer, T.L. Hearn, W.O. Schalla, G.D. Cross, and R.O. Valdiserri. Assessment Of Human T-Cell Lymphotrophic Virus Type I/II Antibody Testing. 1990. Publication of Abstracts for the Sixth International AIDS Conference, June 20-24, 1990, San Francisco, California.

  55. Schalla WO, Hearn TL, Taylor RN, Eavenson E, Valdiserri RO, Essien J: CDC's Model Performance Evaluation Program: Assessment of the Quality of Laboratory Performance for HIV-1 Antibody Testing. Public Health Rep. 1990;105:167-171.
    Ref ID: 94

  56. Taylor RN, Hearn TL, Schalla WO, Valdiserri RO: Indirect Immunofluorescence Test Performance and Questionnaire Results from the Centers for Disease Control Model Performance Evaluation Program for Human Immunodeficiency Virus Type 1 Testing. J.Clin.Microbiol. 1990;28:1799-1807.
    Ref ID: 92

  57. Valdiserri RO, Taylor RN, Hearn TL, Schalla WO, Muir HW: Centers for Disease Control Perspective on Quality Assurance for Human Immunodeficiency Virus Type 1 Antibody Testing. Model Performance Evaluation Program. Arch.Pathol.Lab.Med. 1990;114:263-267.
    Ref ID: 95

  58. W.O. Schalla, G.D. Cross, T.L. Hearn, S.O. Blumer, R.N. Taylor, and R.O. Valdiserri. Accuracy of Western Blot Testing For Human Immunodeficiency Virus Type 1 (HIV-1) Infection. Publication of Abstracts for the 1990 American Society for Microbiology Annual Meeting, May 13-17, 1990, Anaheim, California.

  59. W.O. Schalla, T.L. Hearn, G.D. Cross, S.O. Blumer, R.N. Taylor, and R.O. Valdiserri. Human Immunodeficiency Virus Type-1 (HIV-1) Antibody Testing: Accuracy of Western Blot Results. Publication of Abstracts for the Sixth International AIDS Conference, June 20-24, 1990, San Francisco, California.

  60. W.O. Schalla, T.L. Hearn, R.N. Taylor, E. Eavenson, R.O. Valdiserri. The Centers For Disease Control's Model Performance Evaluation Program: Assessment Of The Quality of Laboratory Testing For Human Immunodeficiency Virus Type 1 (HIV-1) Infection. Collaborative article with Family of SeroSurveys. 1990. Public Health Reports 105(2):167-71.

  61. Benenson AS, Peddecord KM, Hofherr LK, Ascher MS, Taylor RN, Hearn TL: Reporting the Results of Human Immunodeficiency Virus Testing. JAMA 1989;262:3435-3438.
    Ref ID: 91

  62. Hearn, T. L., Schalla, W. O., and Taylor, R. N. Performance Evaluation for Human T-Lymphotropic Virus Type 1 Antibody Testing Being Implemented by CDC. ASTPHLD Newsletter . 1989.
    Ref Type: Newsletter Article
    Ref ID: 122

  63. Hearn, T. L., Schalla, W. O., and Taylor, R. N. Results from CDC's Model Performance Evaluation Program Presented at the Fifth International Conference on AIDS. ASTPHLD Newsletter . 1989.
    Ref Type: Newsletter Article
    Ref ID: 123

  64. Schalla, W. O. and Hearn, T. L. Interpretation and Use of the Western Blot Assay for Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections. MMWR.Morbidity and Mortality Weekly Report 38(S-7), 1-7. 7-21-1989.
    Ref Type: Report
    Ref ID: 106

  65. Schalla, W. O., Hearn, T. L., Valdiserri, R. O., Blumer, S. O., and Taylor, R. N. Current Trends Problems Created by Heat-Inactivation of Serum Specimens Before HIV-1 Antibody Testing. MMWR.Morbidity and Mortality Weekly Report 38(23), 407-408, 413. 6-16-1989. Atlanta, GA, Centers for Disease Control.
    Ref Type: Report
    Ref ID: 195

  66. Anonymous Serological Diagnosis of Human Immunodeficiency Virus Infection by Western Blot Testing. The Consortium for Retrovirus Serology Standardization. JAMA 1988;260:674-679.
    Ref ID: 121

  67. Griffin CW: Model Performance Evaluation Program (HIV testing): Program Overview. Infect.Control Hosp.Epidemiol. 1988;9:364
    Ref ID: 108

  68. Griffin, C. W., Hearn, T. L., and Taylor, R. N. Current Trends Update: Serologic Testing for Antibody to Human Immunodeficiency Virus . MMWR.Morbidity and Mortality Weekly Report 36(52), 833-845. 1-8-1988.
    Ref Type: Report
    Ref ID: 107

  69. Griffin, C. W., Hearn, T. L., Schalla, W. O., and Taylor, R. N. Serologic Testing for Antibody to Human Immunodeficiency Virus. MMWR.Morbidity and Mortality Weekly Report Vol. 36(No. 52), 833-845. 1-8-1988.
    Ref Type: Report
    Ref ID: 214

  70. Schalla, W. O., Hearn, T. L., Griffin, C. W., and Taylor, R. N. Role of the Centers for Disease Control in Monitoring the Quality of Laboratory Testing for Human Immunodeficiency Virus Infection. Clinical Microbiology Newsletter 10(20), 156-159. 10-15-1988.
    Ref Type: Newsletter Article
    Ref ID: 192

  71. Taylor RN, et al: Serological Diagnosis of Human Immunodeficiency Virus Infection by Western Blot testing. JAMA 1988;260:674-679.
    Ref ID: 199

  72. Taylor RN, Przybyszewski VA: Sindrome da immunodeficienza acquisita. Valutazione della efficienza die laboratori nella ricerca degli anticorpi HIV. Sommario dei rilevarmenti esguiti dai Centri per il controllo della malattia. American Journal of Clinical Pathology (Italian edition) 1988;9-22.
    Ref ID: 126

  73. Taylor RN, Przybyszewski VA: Summary of the Centers for Disease Control Human Immunodeficiency Virus (HIV) Performance Evaluation Surveys for 1985 and 1986. Am.J.Clin.Pathol. 1988;89:1-13.
    Ref ID: 125

  74. Schalla WO, Harrison HR': Western Blot Analysis of the Human Serum Response to Mycoplasma hominis. Isr.J.Med.Sci. 1987;23:613-617.
    Ref ID: 119

  75. Schalla, W. O., Hearn, T. L., Griffin, C. W., and Taylor, R. N. Performance Evaluation Program: Testing for Human Immunodeficiency Virus Infection. MMWR.Morbidity and Mortality Weekly Report 26(26), 614. 9-18-1987. Atlanta, GA, Centers for Disease Control.
    Ref Type: Report
    Ref ID: 197

  76. Przybyszewski, V. A. and Taylor, R. N. Allergen-Specific Immunoglobulin E Performance Evaluation Results. 1983. Atlanta, GA, CDC, PHS, HHS.
    Ref Type: Serial (Book,Monograph)
    Ref ID: 210

  77. Taylor RN, Fulford KM: Assessment of Laboratory Improvement by the Centers for Disease Control Diagnostic Immunology Proficiency Testing Program. J.Clin.Microbiol. 1981;13:356-368.
    Ref ID: 220

  78. Taylor, R. N. and Fulford, K. M. Laboratory Improvement in the CDC Proficiency Testing Program. Clinical Immunology Newsletter 2, 15-19. 1981.
    Ref Type: Newsletter Article
    Ref ID: 221

  79. Taylor RN, Fulford KM, Przybyszewski VA, Pope V: Center for Disease Control Diagnostic Immunology Proficiency Testing Program Results for 1978. J.Clin.Microbiol. 1979;10:805-814.
    Ref ID: 128

  80. Taylor RN, Fulford KM, Przybyszewski VA, Pope V: Center for Disease Control Diagnostic Immunology Proficiency Testing Program Results for 1977. J.Clin.Microbiol. 1978;8:388-395.
    Ref ID: 129

  81. Taylor RN, Fulford KM, Przybyszewski VA, Pope V: Center for Disease Control Diagnostic Immunology Proficiency Testing Program Results for 1976. J.Clin.Microbiol. 1977;6:224-232.
    Ref ID: 198

  82. Cross GD, Schalla WO, Taylor RN, Siragusa M, Cohn RD, Gaunt EE: Effect of Specimen Age, Storage Temperature, and Shipping Conditions on Hematology and Flow Cytometric Determinations of Absolute CD4+ T-Cells Counts, (UnPub)
    Ref ID: 30

This page last reviewed: 07/24/2006

spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
spacer FirstGovDHHS Department of Health
and Human Services